The Link Between Rheumatoid Arthritis and Celiac Disease

People with rheumatoid arthritis are roughly 70 percent more likely to be diagnosed with celiac disease than the general population, and the connection runs deeper than coincidence. The two conditions share genetic risk factors, overlapping immune pathways, and even some of the same gut abnormalities, which has prompted researchers to investigate whether one disease actively promotes the other. The relationship is genuinely complex, and what the science has uncovered so far has practical consequences for diagnosis, screening, and even diet.

How Common Is the Overlap?

A large Italian case-control study using the RECORD cohort compared over 70,000 rheumatoid arthritis patients against matched controls and found that about 0.24 percent of RA patients had a celiac disease diagnosis, versus 0.14 percent in the control group. That translated to an odds ratio of 1.70, meaning RA patients were substantially more likely to carry a celiac diagnosis.¹ The gap was especially pronounced in women. Female RA patients had over twice the odds of a celiac diagnosis compared to female controls, while in men the difference was not statistically significant. Given that both RA and celiac disease already affect women at higher rates than men, the female-skewed overlap is striking but not altogether surprising.

These numbers probably underestimate the true overlap. They capture only patients who already had a confirmed celiac diagnosis at the time of data collection. Many people with celiac disease go undiagnosed for years, particularly when their symptoms are subtle or atypical. And RA patients may have their digestive complaints attributed to medication side effects rather than a separate autoimmune process, further delaying recognition.

Does One Condition Cause the Other?

Observational data can show that two diseases cluster together, but it cannot tell you whether one is driving the other or whether they simply share common risk factors. A Mendelian randomization study tackled this question by using genetic variants as proxies to test the direction of causation. The results were asymmetric and somewhat unexpected: a genetic predisposition to RA appeared to causally increase the risk of developing celiac disease, with an odds ratio of about 1.46. But the reverse was not true. Having a genetic predisposition to celiac disease did not significantly increase the risk of RA.²

This does not mean that having RA directly causes celiac disease in a straightforward way. What it suggests is that the biological processes set in motion by RA susceptibility genes, particularly those affecting immune regulation, create conditions in which the gut is more vulnerable to the kind of autoimmune attack that characterizes celiac disease. The traffic, genetically speaking, flows mostly in one direction.

Shared Genetic Roots

Both rheumatoid arthritis and celiac disease are strongly linked to a particular region of the genome that codes for molecules involved in immune recognition. In celiac disease, the critical genes are HLA-DQ2.5 and HLA-DQ8, which produce proteins that present gluten fragments to immune cells. In RA, a different set of variants in the same genomic neighborhood, known as the HLA-DR shared epitope, plays an analogous role for the modified proteins that trigger joint inflammation.³ The two sets of variants are not identical, but they sit close together on the same chromosome and are sometimes inherited as a package, which helps explain why the diseases can cluster in families.

Beyond those major immune-recognition genes, a large meta-analysis identified 14 additional genetic locations shared between the two diseases. Several of these overlapping variants affected genes involved in antigen presentation and T-cell activation, pointing to a common thread in how the immune system gets misdirected in both conditions.⁴ In plain terms, both diseases involve the immune system mistakenly flagging normal or slightly altered proteins as threats and mounting an inflammatory response. The machinery that goes wrong is similar even though the target tissues, the gut lining in celiac and the joint membranes in RA, are different.

Leaky Gut and the Joint Connection

One of the more intriguing pieces of the puzzle is the role of the intestinal barrier. In celiac disease, the gut lining becomes damaged and overly permeable in response to gluten. But increased intestinal permeability is not unique to celiac disease; it has been documented in RA patients as well, sometimes before joint symptoms even appear.⁵ When the gut barrier weakens, bacterial fragments and food proteins can slip into the bloodstream and provoke immune responses in distant tissues, including the joints.

A review in Autoimmunity Reviews described this shared mechanism explicitly, noting that both RA and celiac disease are mediated by enzymes in their respective target organs and that disrupted gut permeability, infections, and shifts in the gut microbial community all feed into the autoimmune cascade in both conditions.⁶ The gut is not merely a bystander; in both diseases, it appears to be a staging ground where immune tolerance breaks down.

The gut microbiome adds another layer. People with either RA or celiac disease tend to have distinct and overlapping shifts in their intestinal bacterial populations compared to healthy controls. A narrative review highlighted that similar patterns of microbial dysbiosis appear in both diseases and that these alterations can worsen disease severity.⁷ Whether the dysbiosis is a cause or a consequence remains an open question, but it reinforces the idea that the gut environment is central to both diseases.

The Antibody Puzzle

This is where things get tricky for clinicians. The standard blood test for celiac disease measures antibodies against tissue transglutaminase (anti-tTG). But RA patients sometimes test positive for these antibodies even when they do not have celiac disease. One study found that about a third of RA patients had elevated anti-tTG levels, compared to roughly 11 percent in people with osteoarthritis and even lower rates in healthy controls.⁸ The researchers concluded that these antibodies may partly reflect tissue damage from inflammation rather than true celiac disease.

A separate study from Algeria found that endomysial antibodies, another celiac marker, were present in about 5.6 percent of RA patients versus 0.3 percent of healthy blood donors. That rate was high enough for the researchers to argue that RA patients should be considered a high-risk group for celiac disease.⁹ However, an Iranian screening study complicates this picture. Among 53 adults with RA, about 11 percent tested positive for anti-tTG, but when those patients underwent intestinal biopsies, none showed the characteristic gut damage of celiac disease.¹⁰

The takeaway for patients and doctors is that a positive celiac antibody test in someone with RA cannot be taken at face value. It may signal genuine celiac disease, but it may also be a byproduct of the inflammatory process itself. Intestinal biopsy remains the gold standard for confirming celiac disease in this population, and rheumatologists who skip that step risk both false diagnoses and unnecessary dietary restriction.

When Joint Pain Is Actually Celiac Disease

The diagnostic confusion can run in the opposite direction too. Celiac disease is classically thought of as a digestive illness, but it does not always present that way. Joint pain is one of the so-called atypical manifestations, and in rare cases it can be the only symptom. A case report described a patient whose sole complaint was joint pain, with no gastrointestinal symptoms at all, and who was ultimately diagnosed with celiac disease.¹¹

A retrospective study of celiac-associated arthritis found that joint inflammation was actually the presenting symptom in most of the cases reviewed, and it was not always accompanied by gastrointestinal complaints or poor growth. The authors emphasized that rheumatologists play a key role in identifying celiac disease because they may be the first specialists these patients see.¹² If a rheumatologist assumes all inflammatory joint disease is RA, celiac disease can go unrecognized for years. And unlike RA, celiac-associated arthritis often improves dramatically with a gluten-free diet, making accurate diagnosis especially consequential.

The practical implication is that anyone being evaluated for new-onset inflammatory arthritis, particularly if their RA-specific antibodies are negative or their pattern of joint involvement is unusual, deserves at least a conversation about celiac screening. This is true even if they have no bloating, diarrhea, or weight loss.

Children and the Double Burden

The overlap between autoimmune joint disease and celiac disease shows up in children too, and the consequences may be more severe. A study of over 300 children with juvenile idiopathic arthritis (JIA) found that 2.4 percent also had celiac disease, roughly two to three times the rate in the general Italian pediatric population. Children who had both conditions were significantly more likely to have a family history of autoimmune disorders, with nearly 90 percent of the dual-diagnosis group having a first- or second-degree relative with an autoimmune disease, compared to about 46 percent of those with JIA alone.¹³

More concerning was the impact on disease severity. Nearly all of the children with both JIA and celiac disease required both conventional and biologic disease-modifying drugs during follow-up, compared to only about a third of those with JIA alone. That is a stark difference and suggests that the presence of celiac disease either worsens the inflammatory arthritis directly, through ongoing gut-driven immune activation, or selects for children with a more aggressive underlying autoimmune tendency. Either way, the finding supports early and routine celiac screening in pediatric arthritis clinics, especially when there is a family history of autoimmunity.

Does Going Gluten-Free Help Rheumatoid Arthritis?

If a leaky gut and gluten-driven inflammation contribute to RA in some patients, the logical next question is whether removing gluten helps. The evidence here is intriguing but thin. A case series reported that RA patients placed on a gluten-free diet showed varying degrees of improvement, with some achieving disease remission, including patients who had been resistant to conventional drug therapies.¹⁴ However, a case series is the weakest form of clinical evidence; it tells you what happened to a handful of patients, not what would happen to most.

A randomized study took a slightly different approach, assigning RA patients to either a gluten-free vegan diet or a standard diet. The gluten-free vegan group showed changes in blood markers that the researchers interpreted as potentially anti-inflammatory and protective against cardiovascular disease, including lower LDL cholesterol and lower levels of oxidized LDL.¹⁵ The catch is that a gluten-free vegan diet changes many things at once, and it is impossible to attribute the benefits specifically to the removal of gluten rather than to the removal of animal products, the increase in vegetable intake, or any number of other dietary shifts.

For RA patients who also have confirmed celiac disease, a strict gluten-free diet is non-negotiable and will likely improve both gut and joint symptoms. For RA patients without celiac disease, the evidence is nowhere near strong enough to recommend a gluten-free diet as standard treatment. That said, a subset of RA patients may have non-celiac gluten sensitivity or subclinical gut inflammation that responds to gluten withdrawal, and the occasional case report of dramatic improvement keeps this area alive as a research question. If you have RA and want to try eliminating gluten, it is reasonable to do so for a defined trial period with your doctor’s knowledge, but it should complement, not replace, your disease-modifying medications.

Shared Immune Pathways Beyond the Gut

Both celiac disease and RA involve a broader immune dysfunction that extends past the specific target organs. Interleukin-17, a signaling molecule produced by a subset of T cells, has been implicated in the inflammatory cascade of numerous autoimmune diseases, RA included.¹⁶ The same pathway is active in the intestinal inflammation seen in celiac disease. This shared reliance on similar inflammatory circuits helps explain why treatments that target one pathway, such as biologic drugs that block certain cytokines, sometimes benefit patients who have overlapping autoimmune conditions.

The enzyme tissue transglutaminase, the target of the main celiac antibody test, is also worth noting in this context. In RA, a chemically similar enzyme called peptidyl arginine deiminase modifies proteins in the joints through a process called citrullination, and the immune system’s reaction to those modified proteins is a hallmark of RA. In celiac disease, tissue transglutaminase modifies gluten peptides through a process called deamidation, and the immune response to those modified peptides drives gut damage. Different enzymes, different tissues, different trigger proteins, but the underlying logic is the same: an enzyme alters a normal protein, and the immune system overreacts to the result.³ This mechanistic parallel is one reason researchers have described the two diseases as mirror images operating on different substrates.

Bone Loss as a Shared Complication

Both RA and celiac disease independently increase the risk of osteoporosis, and having both amplifies the problem. In RA, chronic inflammation directly accelerates bone breakdown, and the corticosteroids often used for treatment compound the effect. In celiac disease, the primary hit to bone comes from malabsorption. Damage to the intestinal lining reduces the absorption of calcium and vitamin D, the two nutrients most critical for maintaining bone density.¹⁷

For someone living with both conditions, the bone-loss pathways stack: inflammation erodes bone from one direction while nutrient deficiency erodes it from another. This makes bone density monitoring and proactive supplementation especially important. It also means that diagnosing celiac disease in an RA patient is not just an academic exercise. Unrecognized celiac disease may be silently worsening bone loss that a rheumatologist would otherwise attribute entirely to RA and its treatment. Correcting the nutritional deficiency through a gluten-free diet and targeted supplementation can slow or partially reverse this component of bone loss, a meaningful win in a population already at elevated fracture risk.

Screening Considerations for Rheumatologists

Despite the accumulating evidence, there is no universal guideline mandating celiac screening for all RA patients. Some researchers have argued strongly for routine screening, pointing to the high rate of celiac-specific antibodies in RA cohorts and the clinical consequences of a missed diagnosis.⁹ Others are more cautious, noting that many of those positive antibody results do not correspond to biopsy-confirmed celiac disease and that widespread screening could generate false alarms and unnecessary invasive testing.

A reasonable middle ground, and one increasingly favored in practice, is targeted screening. Rheumatologists should consider celiac testing for RA patients who have unexplained iron-deficiency anemia, persistent gastrointestinal symptoms not explained by medications, unexplained weight loss, premature osteoporosis, or a family history of celiac disease. The threshold should be lower in women, given the stronger female overlap seen in epidemiological data.¹ And any positive antibody result in an RA patient should be followed by an intestinal biopsy before a celiac diagnosis is confirmed, because the high background rate of anti-tTG positivity in inflammatory arthritis makes serological results alone unreliable.

For patients, the practical message is straightforward: if you have RA and also experience digestive issues, unexplained nutrient deficiencies, or bone loss that seems disproportionate to your disease activity and treatment, bring up celiac disease with your rheumatologist. It is an underappreciated comorbidity that, unlike RA itself, has a clear and effective dietary treatment.